Summary

The Canadian respiratory care device market is critical in offering efficient solutions for the diagnosis, treatment, and management of respiratory disorders. As the country's elderly population expands and environmental variables continue to influence respiratory health, the demand for improved respiratory care devices rises. Home healthcare is on the rise in Canada. At-home respiratory care devices are becoming increasingly popular, allowing people to manage their diseases in a familiar and comfortable setting. Canada is well-known for its universal healthcare system, which gives residents access to vital healthcare services such as respiratory care. This approach assures that all residents, regardless of socioeconomic class, have access to respiratory care devices and treatments, thereby decreasing healthcare inequities. As of Canada's large terrain, isolated and northern towns have restricted access to healthcare facilities. As a result, there is a high demand for portable and telehealth-integrated respiratory care equipment to efficiently service these populations. Canada prioritizes the education of healthcare personnel in the proper use and management of respiratory care equipment. Comprehensive training programs guarantee that clinicians and respiratory therapists are properly prepared to deliver care. Individuals with chronic respiratory failure in Canada can get care in the comfort of their own homes because of well-established home ventilation programs. This includes the provision of ventilators as well as continuing assistance. Canadian healthcare organizations and professionals actively participate in international respiratory health initiatives and collaborate with global partners to advance the field of respiratory care.

According to the research report "Canada Respiratory Care Devices Market Overview, 2028," published by Bonafide Research, the Canada Respiratory Care Devices market is expected to add more than USD 300 Million from 2023 to 2028. The cold climate of Canada, as well as the concomitant increase in respiratory disorders throughout the winter months, has resulted in an emphasis on respiratory treatment and the development of specific devices for treating cold-related respiratory diseases. In Canada, home oxygen therapy is a frequent treatment for respiratory diseases. Patients are given portable oxygen cylinders or oxygen concentrators to help them manage their diseases at home. In place of more effective treatment, Canada's pharmaceutical industry frequently collaborates with medical device makers to develop combination therapies that incorporate both drug and respiratory care devices. Technological advancements have resulted in the creation of smart and connected respiratory care devices. These devices can gather and send data, providing patients and healthcare providers with real-time information. This tendency promotes treatment adherence and allows for timely treatment plan modifications. In Canada, the capacity to remotely monitor patients utilizing respiratory care devices has become critical. Healthcare personnel can monitor patients' lung function, oxygen levels, and device usage, allowing for proactive interventions and treatment plan changes. Ventilators used in critical care settings are incorporating advanced ventilation modes to improve patient outcomes. This includes modes that adapt to patients' changing needs, reducing the risk of ventilator-induced lung injuries. Blockchain technology is being explored for securing and managing patient data related to respiratory care devices. This technology ensures data integrity, privacy, and secure sharing among healthcare stakeholders.

In terms of product type market is segmented into therapeutic devices, monitoring devices, diagnostic devices and consumables and accessories. Consumables and accessories segment is expected to register highest growth rate in Canada respiratory devices market. Consumables like inhalers and nebulizer solutions are crucial for managing symptoms like shortness of breath, wheezing, and coughing associated with conditions such as asthma and COPD. They help individuals breathe more comfortably and improve their quality of life. Masks and interfaces are crucial components of positive airway pressure (PAP) devices, ensuring a secure and comfortable fit. They promote therapy adherence and patient comfort. Furthermore based on disease indication market is divided into chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases and other disease indications. Infectious disease indication is expected to grow at significant pace in Canada respiratory devices market. In Canada, respiratory illnesses such as influenza, respiratory syncytial virus (RSV), and tuberculosis continue to be a major public health concern. As these infections can cause severe respiratory symptoms and consequences, there is a high demand for respiratory devices for both detection and treatment. In order to prevent and minimize the spread of respiratory illnesses, the Canadian government promotes vaccination programs. The growing emphasis on vaccination, particularly during flu seasons, requires the development of diagnostic and monitoring equipment to measure vaccine effectiveness and identify outbreak infections. Because Canada is a worldwide travel center, it must be attentive to monitoring and treating infectious diseases. In order to identify potential instances, screening and diagnostic instruments are essential at airports and border crossings.

Based on end user segment market is divided into hospitals, ambulatory care centers (ACCs), home care settings and other end user. Home care setting segment is expected to grow at fastest rate in Canada respiratory care devices market. Canada's population is increasingly aging, and many seniors choose to receive healthcare services in the privacy of their own homes. Because many respiratory disorders are chronic and more common in older people, home care is the recommended option for long-term maintenance. Home care is frequently preferred by patients over hospitalization or institutional care. Individuals can keep their freedom, comfort, and familiar surroundings while receiving required respiratory treatment at home. Technological breakthroughs have resulted in the creation of portable and user-friendly respiratory care equipment suitable for use at home. Portable oxygen concentrators, CPAP devices, and nebulizers are now small, lightweight, and simple to use. The integration of telehealth and remote monitoring platforms has expanded the capabilities of home-based respiratory care. Patients can connect with healthcare providers virtually, reducing the need for frequent clinic visits.

Considered in this report:
• Geography: Canada
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• Canada Respiratory Care Devices market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type:
• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables and Accessories

By Disease Indication:
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other Disease Indications

By End User:
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home Care Settings
• Other End User

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Respiratory Care Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents